Invion Ltd (ivx) Logo

Invion Ltd (IVX)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials

IVX ASX Chart

Snapshot

Invion Limited (IVX) is a life-sciences company focussed on transforming Photodynamic Therapy (PDT) for novel and effective treatments for cancer, atherosclerosis, and infectious diseases. Invion is leading the global research and development of the Photosoft technology and holds the Australia and New Zealand license and distribution rights to the Photosoft technology.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) -21.14%
vs ASX 200 (1yr) -32.33%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,335 of 2,385
Sector Rank 113 of 226

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies GMV / IDT / IVQ
EPS $0.00
DPS $0.00
Book Value Per Share $0.001

Broker Consensus

IVX is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Top Market Index News

More News

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Kew East VIC 3102
Website www.inviongroup.com
Registry Link Market Services
Auditor Grant Thornton Audit Pty Ltd
Date Listed 15 Feb 2010

Upcoming Calendar (Forecasted)

Date Event
29/08/2024 Report (Prelim)
26/09/2024 Report (Annual)
26/02/2025 Report (Interim)

Former Company Names

  • Cbio Limited (CBZ), 04/09/2012.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

IVX directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
18/01/24 Robert (Rob) Merriel Buy +2,900,000 $0.005 $13,050 Exercise of options
18/01/24 Robert (Rob) Merriel Exercise 2,900,000 $0.005 $13,050 Exercise of options
01/05/23 Robert (Rob) Merriel Buy +1,540,125 $0.007 $10,780 Exercise of options
01/05/23 Robert (Rob) Merriel Exercise 1,540,125 $0.007 $10,780 Exercise of options
17/11/22 Chiat Chew Issued 22,013,745 $0.010 $231,144 Issue of options
16/09/22 Alistair Bennallack Buy +3,578,437 $0.013 $46,519 Exercise of options
16/09/22 Alistair Bennallack Exercise 3,578,437 $0.013 $46,519 Exercise of options
12/09/22 Chiat Chew Issued 2,243,898 $0.013 $29,170 Director remuneration
12/09/22 Robert (Rob) Merriel Issued 1,240,726 $0.013 $16,129 Director remuneration
12/09/22 Alan Yamashita Issued 1,364,789 $0.013 $17,742 Director remuneration
12/09/22 Alistair Bennallack Issued 1,240,726 $0.013 $16,129 Director remuneration
16/06/22 Alistair Bennallack Issued 1,016,546 $0.009 $9,148 Director remuneration
16/06/22 Robert (Rob) Merriel Issued 1,016,546 $0.009 $9,148 Director remuneration
16/06/22 Alan Yamashita Issued 1,118,192 $0.009 $10,063 Director remuneration
16/06/22 Chiat Chew Issued 1,838,460 $0.009 $16,546 Director remuneration
15/03/22 Chiat Chew Issued 1,291,619 $0.015 $20,020 Director remuneration
15/03/22 Robert (Rob) Merriel Issued 714,179 $0.015 $11,069 Director remuneration
15/03/22 Alan Yamashita Issued 785,591 $0.015 $12,176 Director remuneration
15/03/22 Alan Yamashita Issued 785,591 $0.015 $12,176 Director remuneration
15/03/22 Alistair Bennallack Issued 714,179 $0.015 $11,069 Director remuneration
07/12/21 Chiat Chew Issued 1,097,756 $0.018 $19,759 Director remuneration
07/12/21 Robert (Rob) Merriel Issued 606,986 $0.018 $10,925 Director remuneration
07/12/21 Alan Yamashita Issued 667,680 $0.018 $12,018 Director remuneration
07/12/21 Alistair Bennallack Issued 606,986 $0.018 $10,925 Director remuneration
05/10/21 Alistair Bennallack Buy +2,838,217 $0.014 $39,735 Exercise of options
05/10/21 Alistair Bennallack Exercise 2,838,217 $0.014 $39,735 Exercise of options
04/10/21 Robert (Rob) Merriel Sell +1,000,000 $0.014 ($14,000) On-market trade
30/09/21 Chiat Chew Issued 138,488,557 $0.017 $2,354,305 Issue of options
30/09/21 Alistair Bennallack Issued 2,838,217 $0.014 $39,735 Director remuneration
30/09/21 Robert (Rob) Merriel Buy +1,000,000 $0.014 $14,000 Exercise of options
30/09/21 Robert (Rob) Merriel Exercise 1,000,000 $0.014 $14,000 Exercise of options
16/09/21 Chiat Chew Issued 1,727,211 $0.015 $25,908 Director remuneration
16/09/21 Robert (Rob) Merriel Issued 959,386 $0.015 $14,390 Director remuneration
16/09/21 Alan Yamashita Issued 1,050,528 $0.015 $15,757 Director remuneration
17/06/21 Robert (Rob) Merriel Sell +1,500,000 $0.015 ($22,500) On-market trade
10/06/21 Chiat Chew Issued 1,589,620 $0.016 $25,433 Director remuneration
10/06/21 Robert (Rob) Merriel Issued 882,961 $0.016 $14,127 Director remuneration
10/06/21 Alan Yamashita Issued 966,842 $0.016 $15,469 Director remuneration
04/06/21 Robert (Rob) Merriel Sell +1,000,000 $0.017 ($17,000) On-market trade
04/06/21 Robert (Rob) Merriel Buy +1,500,000 $0.017 $25,500 Exercise of options
04/06/21 Robert (Rob) Merriel Exercise 1,500,000 $0.017 $25,500 Exercise of options
01/06/21 Alistair Bennallack Buy +13,333,333 $0.020 $266,666 As advised by the company
07/04/21 Robert (Rob) Merriel Buy +250,000 $0.009 $2,250 Exercise of options
07/04/21 Robert (Rob) Merriel Exercise 250,000 $0.009 $2,250 Exercise of options
01/04/21 Chiat Chew Issued 2,525,590 $0.009 $22,730 Director remuneration
01/04/21 Robert (Rob) Merriel Issued 1,402,849 $0.009 $12,625 Director remuneration
01/04/21 Alan Yamashita Issued 1,536,120 $0.009 $13,825 Director remuneration
22/12/20 Rob Merriel Buy +750,000 $0.010 $7,500 Exercise of options
22/12/20 Rob Merriel Exercise 750,000 $0.010 $7,500 Exercise of options
09/12/20 Alan Yamashita Issued 1,222,558 $0.012 $14,670 Director remuneration
09/12/20 Rob Merriel Issued 1,116,492 $0.012 $13,397 Director remuneration
09/12/20 Chiat Chew Issued 2,010,052 $0.012 $24,120 Director remuneration
30/10/20 Craig Newton Expiry 35,434,899 $0.011 $389,783 Options expired
29/10/20 Craig Newton Issued 24,165,189 $0.011 $256,151 Director remuneration
29/10/20 Craig Newton Issued 6,814,404 $0.010 $68,144 Issue of options
22/10/20 Chiat Chew Issued 3,537,736 $0.011 $38,915 Issue of options
22/10/20 Alan Yamashita Issued 2,151,887 $0.011 $23,670 Issue of options
31/10/19 Gregory (Greg) Collier Sell +3,000,000 $0.013 ($39,000) On-market trade
12/02/19 Gregory (Greg) Collier Issued 136,288,073 $0.018 $2,453,185 Issue of options
12/02/19 Gregory (Greg) Collier Issued 8,333,333 $0.018 $150,000 Issue of securities
12/02/19 Chiat Chew Issued 27,257,615 $0.018 $490,637 Issue of options
12/02/19 James Campbell Issued 20,443,211 $0.018 $367,978 Issue of options
21/12/18 Chiat Chew Buy +850,000 $0.019 $15,895 On-market trade
13/12/18 Chiat Chew Buy +790,000 $0.019 $14,773 On-market trade
09/11/18 Mitchell Glass Expiry 8,812,500 $0.024 $211,500 Options expired
17/04/18 Mitchell Glass Sell +10,000,000 $0.034 ($339,465) On-market trade
15/03/18 Chiat Chew Issued 124,621,194 $0.002 $249,242 Rights issue
15/03/18 Gregory (Greg) Collier Issued 5,357,167 $0.002 $10,714 Rights issue
15/03/18 James Campbell Issued 956,978 $0.002 $1,914 Rights issue
15/03/18 Warren Brown Issued 3,279,894 $0.002 $6,560 Rights issue
09/11/17 James Campbell Expiry 1,500,000 $0.006 $9,000 Options expired
09/11/17 Mitchell Glass Expiry 10,000,000 $0.006 $60,000 Options expired
26/06/17 James Campbell Transfer 256,236 $0.002 $512 On-market transfer
26/06/17 James Campbell Transfer 256,236 $0.002 $512 On-market transfer
10/12/15 James Campbell Issued 2,054,794 $0.007 $15,000 Participation in share purchase plan
10/12/15 Gregory (Greg) Collier Issued 2,054,794 $0.007 $15,000 Participation in share purchase plan
10/12/15 Mitchell Glass Issued 2,054,794 $0.007 $15,000 Participation in share purchase plan
10/12/15 James Brett Heading Issued 2,054,794 $0.007 $15,000 Participation in share purchase plan
29/04/15 Ralph Craven Transfer 1,671,429 $0.024 $40,114 Off-market transfer
29/04/15 Ralph Craven Transfer 1,671,429 $0.024 $40,114 Off-market transfer
24/04/15 Ralph Craven Issued 371,429 $0.025 $9,286 Rights issue
24/04/15 James Brett Heading Issued 58,546 $0.025 $1,464 Rights issue
24/04/15 Gregory (Greg) Collier Issued 264,286 $0.025 $6,607 Rights issue
03/12/14 Mitchell Glass Buy +993,527 $0.058 $57,426 On-market trade
01/12/14 Ralph Craven Buy +200,000 $0.057 $11,324 On-market trade
24/11/14 Gregory (Greg) Collier Buy +400,000 $0.059 $23,400 On-market trade
24/11/14 Mitchell Glass Issued 8,812,500 $0.060 $528,750 Issue of options
Show All

Director Interests

The current holdings of IVX directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Robert (Rob) Merriel 18/01/2024 4,440,125 N/A 20,443,211 N/A
Alistair Bennallack 28/09/2023 19,749,987 N/A 20,443,211 N/A
Alan Yamashita 28/09/2023 N/A N/A 10,864,187 N/A
Chiat Chew 28/09/2023 N/A 546,857,721 178,364,244 N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Sep 20, 2023.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Polar Ventures Limited 545,217,721 8.49%
BNP Paribas Nominees Pty Ltd <IB Au Noms Retail Client Drp> 537,894,371 8.38%
Rmw Cho Health Technology Limited 321,428,571 5.01%
Rmwc Pty Ltd <Rmwc Family A/C> 314,547,156 4.90%
Mr Honsue Cho 284,626,482 4.43%
Ngpdt Greater China Limited 272,652,297 4.25%
Mei Jun Lin 272,500,000 4.24%
Acslnc Pty Ltd <Acslnc Family A/C> 229,950,000 3.58%
Citicorp Nominees Pty Limited 162,657,602 2.53%
Shengli Wang 136,288,074 2.12%
Yong Chen 110,000,000 1.71%
Ms Dandan Wang 104,719,526 1.63%
Surfit Capital Pty Ltd 100,000,000 1.56%
Mr Yong Chen 93,253,079 1.45%
Mr Shengwei Ou 77,304,171 1.20%
Shubo Miao 73,333,333 1.14%
Mr Esmond Wong & Mrs Quynh Thi Kim Nguyen 67,564,765 1.05%
Eq Investment Pty Ltd 62,500,000 0.97%
Ms Yinghua Ma 61,000,000 0.95%
Hsbc Custody Nominees (Australia) Limited 51,463,958 0.80%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 347 370 269 1,950 1,746 4,682

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Honsue Cho 20/09/2023 284,626,482 4.43
Rmwc Pty Ltd (Rmwc Family A/C) 20/09/2023 314,547,156 4.90
Polar Ventures Limited 20/09/2023 545,217,721 8.49
Polar Ventures Limited 20/09/2023 1,640,000 0.03
Rmw Cho Health Technology Limited 20/09/2023 321,428,571 5.01

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2023 $0.004 30 June
2022 $0.009 30 June
2021 $0.013 30 June
2020 $0.008 30 June
2019 $0.015 28 June
2018 $0.034 29 June
2017 $0.002 28 June
2016 $0.004 28 June
2015 $0.019 30 June
2014 $0.070 30 June
IVX Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.